You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • DPP4i, thiazolidinediones, or insulin and risks of cancer in patients with type 2 diabetes mellitus on metformin–sulfonylurea dual therapy with inadequate control

Article info

Article menu

Download PDFPDF

XML
Emerging Technologies, Pharmacology and Therapeutics
DPP4i, thiazolidinediones, or insulin and risks of cancer in patients with type 2 diabetes mellitus on metformin–sulfonylurea dual therapy with inadequate control

Authors

  • Carlos K H Wong Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China PubMed articlesGoogle scholar articles
  • Kenneth K C Man Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, ChinaResearch Department of Policy and Practice, University College London School of Pharmacy, London, UK PubMed articlesGoogle scholar articles
  • Esther W Y Chan Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China PubMed articlesGoogle scholar articles
  • Tingting Wu Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China PubMed articlesGoogle scholar articles
  • Emily T Y Tse Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China PubMed articlesGoogle scholar articles
  • Ian C K Wong Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, ChinaResearch Department of Policy and Practice, University College London School of Pharmacy, London, UK PubMed articlesGoogle scholar articles
  • Cindy L K Lam Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Carlos K H Wong; carlosho{at}hku.hk
View Full Text

Citation

Wong CKH, Man KKC, Chan EWY, et al
DPP4i, thiazolidinediones, or insulin and risks of cancer in patients with type 2 diabetes mellitus on metformin–sulfonylurea dual therapy with inadequate control
BMJ Open Diabetes Research and Care 2020;8:e001346. doi: 10.1136/bmjdrc-2020-001346

Publication history

  • Received March 10, 2020
  • Revised April 15, 2020
  • Accepted May 4, 2020
  • First published June 11, 2020.
Online issue publication 
June 08, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.